Tender Corp Expands Manufacturing to Meet Growing Demand for Insect Repellent 

With the recent buzz around increased cases of insect borne illnesses like the Zika Virus, people are purchasing more insect repellent and stores are working to keep up with this increased demand, say executives at Tender Corporation, makers of insect repellents such as Natrapel and Ben’s. In turn, Tender Corp. recently moved to its new 117,250 sq. ft. world headquarters where they are housing expanded production facilities and management offices. This new state-of-the-art facility is allowing Tender Corp. to quickly manufacture product and keep up with the growing demand, says the company.

Tender’s new facility meets or exceeds the FDA’s and the EPA’s (as well as their Canadian and European equivalents) requirements for not only the production of over the counter medications, medical Devices, and insect repellents, but also all local, state, and Federal requirements for storage, use, production, handling, and documented off-site waste disposal.

“People are stocking up on insect repellent and we expect them to purchase even more as mosquito and biting insect season peaks,” said Jason Cartwright, CEO of Tender Corporation. “Our new office space allows us to quickly turn around orders from our retail partners and provide consumers with insect repellent to protect them this season.”